SK pharmteco Executive and Leadership Team

November, 2026

Leadership Overview

SK pharmteco has 4 executives leading key functions including strategy, operations, organizational alignment, and small molecule manufacturing.

Focused on advancing global health through innovative drug development, SK pharmteco delivers comprehensive CDMO services for small molecules, biologics, and cell and gene therapies to clients worldwide.

Leadership Roles at SK pharmteco

  • Chief Executive Officer - Joerg Ahlgrimm
  • Chief Operating Officer - David Lowndes
  • President, Small Molecule (North America) - Kalen Minvielle
  • Chief of Staff - Gregory Cloetingh
  • Joerg Ahlgrimm - Chief Executive Officer

    Joerg Ahlgrimm, the Chief Executive Officer at SK pharmteco, directs the overarching corporate strategy and global vision for the organization. Overseeing the integration of small molecule, biologic, and cell and gene therapy capabilities, the Chief Executive Officer ensures that the company maintains a competitive edge within the international CDMO market. Joerg Ahlgrimm drives the expansion of the CGMP facility network, facilitating seamless technology transfer across diverse therapeutic programs. By aligning internal resources with client requirements, the Chief Executive Officer fosters a culture of operational excellence and regulatory compliance. This leadership role involves constant engagement with the Board to secure long-term growth and market stability. Through the optimization of manufacturing processes, the Chief Executive Officer supports the delivery of innovative therapies to patients globally. Ultimately, Ahlgrimm secures the company's position as a premier partner for pharmaceutical development.
    Joerg Ahlgrimm

    David Lowndes - Chief Operating Officer

    David Lowndes, the Chief Operating Officer at SK pharmteco, manages the daily execution of complex manufacturing operations across the global network. Focusing on the efficiency of API drug development and production, the Chief Operating Officer implements rigorous quality standards to ensure consistent project delivery. David Lowndes coordinates cross-functional teams to streamline technology transfer, reducing time-to-market for critical therapeutic programs. By overseeing the technical infrastructure and supply chain logistics, the Chief Operating Officer maintains high performance across all CGMP facilities. This role requires constant collaboration with site leaders to resolve operational bottlenecks and enhance production capacity. Through the application of advanced manufacturing methodologies, the Chief Operating Officer drives significant improvements in output and reliability. Ultimately, Lowndes ensures that every client project meets stringent regulatory requirements while maintaining the highest standards of safety and operational excellence.

    Kalen Minvielle - President, Small Molecule (North America)

    Kalen Minvielle, the President, Small Molecule (North America) at SK pharmteco, directs all regional operations related to small molecule drug development and manufacturing. Overseeing the North American market expansion, the President, Small Molecule (North America) ensures that local facilities meet the specific demands of regional clients. Kalen Minvielle manages the technical teams responsible for API synthesis and regulatory support, driving project success from early development through commercial scale. By fostering strong relationships with regional partners, the President, Small Molecule (North America) secures a robust pipeline of therapeutic programs. This leadership role involves aligning regional manufacturing capabilities with the broader global strategy to maintain consistent quality standards. Through the optimization of local production workflows, the President, Small Molecule (North America) enhances the company's competitive standing in the North American pharmaceutical sector. Ultimately, Minvielle delivers critical manufacturing solutions that accelerate the development of life-saving medications.

    Gregory Cloetingh - Chief of Staff

    Gregory Cloetingh, the Chief of Staff at SK pharmteco, architects the internal communication frameworks and strategic alignment initiatives that connect executive leadership with operational departments. Managing the flow of information across the organization, the Chief of Staff ensures that corporate objectives remain clear and actionable for all teams. Gregory Cloetingh facilitates high-level project management, enabling the company to execute complex drug development programs with precision. By coordinating efforts between the C-suite and functional leads, the Chief of Staff optimizes decision-making processes and resource allocation. This role involves monitoring key performance indicators to track progress against long-term business goals. Through the implementation of structured governance, the Chief of Staff supports the seamless integration of new technologies and service offerings. Ultimately, Cloetingh drives organizational efficiency, ensuring that the company remains agile and responsive to the evolving needs of the global pharmaceutical industry.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding SK pharmteco Top Executives and Leadership Team

    Who leads SK pharmteco?
    SK pharmteco is led by Joerg Ahlgrimm (Chief Executive Officer), along with executives such as David Lowndes (Chief Operating Officer) and Kalen Minvielle (President, Small Molecule (North America)).
    Who is part of SK pharmteco’s executive team?
    The executive team of SK pharmteco includes leaders such as Joerg Ahlgrimm (Chief Executive Officer), David Lowndes (Chief Operating Officer), Kalen Minvielle (President, Small Molecule (North America)) and other senior executives.
    How many executives does SK pharmteco have?
    SK pharmteco has 4 executives leading key business areas.
    What roles are included in SK pharmteco’s leadership team?
    The leadership team of SK pharmteco includes roles such as Chief Executive Officer, Chief Operating Officer, President, Small Molecule (North America), Chief of Staff.